Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1991 1
1992 2
1993 2
1994 2
1995 8
1996 2
1997 1
1998 4
1999 2
2000 2
2001 1
2002 1
2003 5
2004 1
2005 3
2006 3
2007 6
2008 1
2009 6
2010 5
2011 4
2012 16
2013 10
2014 17
2015 10
2016 18
2017 14
2018 16
2019 24
2020 32
2021 18
2022 32
2023 25
2024 49
2025 33

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

347 results

Results by year

Filters applied: . Clear all
Page 1
Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial.
Allen JA, Lin J, Basta I, Dysgaard T, Eggers C, Guptill JT, Gwathmey KG, Hewamadduma C, Hofman E, Hussain YM, Kuwabara S, Le Masson G, Leypoldt F, Chang T, Lipowska M, Lowe M, Lauria G, Querol L, Simu MA, Suresh N, Tse A, Ulrichts P, Van Hoorick B, Yamasaki R, Lewis RA, van Doorn PA; ADHERE Study Group. Allen JA, et al. Lancet Neurol. 2024 Oct;23(10):1013-1024. doi: 10.1016/S1474-4422(24)00309-0. Lancet Neurol. 2024. PMID: 39304241 Clinical Trial.
A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis.
Nowak RJ, Benatar M, Ciafaloni E, Howard JF Jr, Leite MI, Utsugisawa K, Vissing J, Rojavin M, Li Q, Tang F, Wu Y, Rampal N, Cheng S; MINT Investigators. Nowak RJ, et al. N Engl J Med. 2025 Jun 19;392(23):2309-2320. doi: 10.1056/NEJMoa2501561. Epub 2025 Apr 8. N Engl J Med. 2025. PMID: 40202593 Clinical Trial.
Efgartigimod for generalized myasthenia gravis: A multicenter real-world cohort study in China.
Luo S, Jiang Q, Zeng W, Wang Q, Zou Z, Yu Y, Hong D, Zeng Q, Tan S, Zhang Z, Zhang Y, Guo X, Chen J, Zhao Z, Huang S, Shi J, Chen Y, Du L, Yan C, Xi J, Song J, Zhao C; Chinese Myasthenia Gravis Collaborating Group (CMGCG). Luo S, et al. Ann Clin Transl Neurol. 2024 Aug;11(8):2212-2221. doi: 10.1002/acn3.52142. Epub 2024 Jul 7. Ann Clin Transl Neurol. 2024. PMID: 38973109 Free PMC article.
Short-term outcome prediction for myasthenia gravis: an explainable machine learning model.
Zhong H, Ruan Z, Yan C, Lv Z, Zheng X, Goh LY, Xi J, Song J, Luo L, Chu L, Tan S, Zhang C, Bu B, Da Y, Duan R, Yang H, Luo S, Chang T, Zhao C; Pan-Yangtze River Delta Alliance for Neuromuscular Disorders (PYDAN). Zhong H, et al. Among authors: da y. Ther Adv Neurol Disord. 2023 Feb 24;16:17562864231154976. doi: 10.1177/17562864231154976. eCollection 2023. Ther Adv Neurol Disord. 2023. PMID: 36860354 Free PMC article.
A Multicenter Study of Hereditary Transthyretin Amyloidosis in China.
Chu X, Kang J, Xu J, Jiang H, Wu ZY, Wang Q, Li W, Li J, Luan X, Sun C, Zou Z, Zhu M, Chen B, Liu X, Zhou M, Du K, Huang T, Fan D, Zhang Z, Hong D, Lin J, Cao L, Qian M, Wang Z, Yuan Y, Da Y, Yu H, Zhang R, Meng L. Chu X, et al. Among authors: da y. Ann Neurol. 2025 Jun;97(6):1158-1167. doi: 10.1002/ana.27203. Epub 2025 Feb 20. Ann Neurol. 2025. PMID: 39976297
Response to Eura et al.
Yu J, Shan J, Yu M, Di L, Xie Z, Zhang W, Lv H, Meng L, Zheng Y, Zhao Y, Gang Q, Guo X, Wang Y, Xi J, Zhu W, Da Y, Hong D, Yuan Y, Yan C, Wang Z, Deng J. Yu J, et al. Among authors: da y. Am J Hum Genet. 2022 Nov 3;109(11):2090-2091. doi: 10.1016/j.ajhg.2022.10.003. Am J Hum Genet. 2022. PMID: 36332613 Free PMC article. No abstract available.
347 results